The cash flow of Johnson & Johnson over the past 10 years
Chart Johnson & Johnson: operating cash flow, capital expenditures, free cash flow, fiscal 2016–2025 Open the chart →In fiscal 2025, the latest fiscal year on file, Johnson & Johnson's operating cash flow was $24.53B and its capital expenditures $4.83B, leaving free cash flow of $19.7B. Free cash flow was above zero in all 10 years shown. It ranged from $15.54B in fiscal 2016 to $20.19B in fiscal 2020. Capital expenditures were highest in fiscal 2025, at $4.83B.
Year by year
| Fiscal year | Operating cash flow | Capital expenditures | Free cash flow* |
|---|---|---|---|
| 2025ended Dec 28, 2025 | $24.53B | $4.83B | $19.7B |
| 2024ended Dec 29, 2024 | $24.27B | $4.42B | $19.84B |
| 2023ended Dec 31, 2023 | $22.79B | $4.54B | $18.25B |
| 2022ended Jan 1, 2023 | $21.19B | $4.01B | $17.18B |
| 2021ended Jan 2, 2022 | $23.41B | $3.65B | $19.76B |
| 2020ended Jan 3, 2021 | $23.54B | $3.35B | $20.19B |
| 2019ended Dec 29, 2019 | $23.42B | $3.5B | $19.92B |
| 2018ended Dec 30, 2018 | $22.2B | $3.67B | $18.53B |
| 2017ended Dec 31, 2017 | $21.06B | $3.28B | $17.78B |
| 2016ended Jan 1, 2017 | $18.77B | $3.23B | $15.54B |
Fiscal years as Johnson & Johnson reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Johnson & Johnson
- The revenue of Johnson & Johnson
- The profitability of Johnson & Johnson
- The debt of Johnson & Johnson
- The dividends of Johnson & Johnson
- All of Johnson & Johnson's financials, charted
Companies of a similar size
- AMDADVANCED MICRO DEVICES INC
- ONCBEONE MEDICINES LTD.
- JPMJPMORGAN CHASE & CO
- MAMastercard Incorporated
- WMTWalmart Inc.
Not investment advice. This page shows what Johnson & Johnson filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.